(PDF) Would Hemodialysis Patients Benefit From a

Would Hemodialysis Patients Benefit From a Staphylococcus Aureus Vaccine?

Kidney International - United States

doi 10.1016/j.kint.2018.10.023

Full Text

Abstract

Available in full text

Categories

Date

March 1, 2019

Authors

Roisin Connolly

Hilary Humphreys

Rachel M. McLoughlin

Publisher

Elsevier BV

Related search

The Potential Economic Value of a Staphylococcus Aureus Vaccine Among Hemodialysis Patients

Molecular Medicine

Infectious Diseases

Occupational Health

English

Antimicrobial Activity of Daptomycin and Selected Comparators Tested Against Bloodstream Staphylococcus Aureus Isolates From Hemodialysis Patients

International Journal of Infectious Diseases

Infectious Diseases

English

Development of a Mimotope Vaccine Targeting the Staphylococcus Aureus Quorum Sensing Pathway

Multidisciplinary

English

593 Clustering of Staphylococcus Aureus (Sa) Infections in a Pediatric Hemodialysis (Hmd) Unit

Pediatric Research

English

Developing a Universal Staphylococcus Aureus Vaccine: Why Aren?t We There Yet?

Internal Medicine: Open Access

English

Chorismate Synthase From Staphylococcus Aureus

English

Methicillin Resistance in Staphylococcus Aureus Infections Among Patients Colonized With Methicillin-Susceptible Staphylococcus Aureus

Clinical Microbiology and Infection

Infectious Diseases

English

Safety and Immunogenicity of a Novel Staphylococcus Aureus Vaccine: Results From the First Study of the Vaccine Dose Range in Humans

Clinical and Vaccine Immunology

Clinical Biochemistry

English

Are Methicillin-Susceptible Staphylococcus Aureus Carriers Protected From Methicillin-Resistant Staphylococcus Aureus Infections?

Clinical Microbiology and Infection

Infectious Diseases

English